Left Atrial Appendage Closure Devices Market Size Worth $ 3.83 Billion by 2028 | CAGR 19.3%

IMARC Group, a leading market research company, has recently releases report titled "Left Atrial Appendage Closure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global left atrial appendage closure devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the left atrial appendage closure devices market?

The global left atrial appendage closure devices market size reached US$ 1.23 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.83 Billion by 2028, exhibiting a growth rate (CAGR) of 19.3 % during 2023-2028.

What is left atrial appendage closure devices?

Left atrial appendage closure (LAAC) devices are medical devices implanted in the heart to reduce the risk of stroke in non-valvular atrial fibrillation (AFib) patients. The left atrial appendage (LAA) is a small pouch-like structure in the heart muscle that can cause blood clots, leading to stroke in AFib patients. LAAC devices are implanted to permanently block the LAA, prevent the formation of blood clots, and lower the risk of stroke. They are placed through minimally invasive procedures involving a catheter inserted through a small incision in the arm or groin. As a result, LAAC devices are widely adopted in hospitals and ambulatory surgery centers across the globe.

Request for a free sample copy of this report: https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market/requestsample

What are the growth prospects and trends in the left atrial appendage closure devices?

The market is primarily driven by the rising occurrences of atrial fibrillation. In addition, the increasing consumption of high-calorie diets, smoking, and sedentary lifestyles among working professionals are contributing to market growth. Moreover, the emerging technological advancements in closure devices with enhanced efficacy and safety of the product and the focus on developing minimally invasive (MI) devices to minimize recovery time and improve patient comfort, represents another major growth-inducing factor. Besides this, the growing geriatric population susceptible to cardiovascular diseases (CVDs), the introduction of electrophysiology procedures, and increasing awareness of alternative treatment options is accelerating the product adoption rate. Furthermore, expanding healthcare infrastructure, extensive research and development (R&D) activities among key players, and the adoption of robotic-assisted closure devices are also creating a positive market outlook.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Insights:

Endocardial LAA Devices
Epicardial LAA Devices

End User Insights:

Hospitals
Ambulatory Surgery Centers
Others

Breakup by Geography:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Who are the key players operating in the industry?

List of Key Companies Covered in this Market Report:

Abbott Laboratories
AtriCure Inc.
Boston Scientific Corporation
Cardia Inc.
Lepu Medical Technology (Beijing) Co. Ltd.
LifeTech Scientific

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=7138&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.